Table 1 Profile of Influenza prevalence and management in two consecutive seasons without (2017/18) and with POCT Influenza testing (2018/19)
Parameter | 2017 | 2018 | ||||
|---|---|---|---|---|---|---|
No. patients screened for influenza A and B | 292 | 272 | ||||
No. of influenza-positive patients | A | B | Total | A | B | Total |
23 | 42 | 65 | 60 | 1 | 61 | |
No. of patients receiving Oseltamivir | 23 (8%) | 51 (19%) | ||||
No. of influenza-positive patients receiving Oseltamivir | 18 (28%) | 42 (69%) | ||||
Defined daily dosing (DDD) for antibiotics | 191.6 | 132.7 | ||||
No. of patients isolated/cohorted on admission | 34 (52%) | 43 (70%) | ||||
Average influenza-positive patient length of stay (bed nights) | 5.26 ± 3.4 | 3.73 ± 2.1* | ||||